Sunday, July 12, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 59 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9682982

    Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  2. US 9682052

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 20, 2017 · Expires Jun 15, 2037

    granted
  3. US 9676802

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  4. US 9675697

    BET bromodomain inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  5. US 9677143

    Compositions and methods for the identification of inhibitors of retroviral infection

    TRANA DISCOVERY, INC. · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  6. US 9676759

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  7. US 9670213

    Pteridine ketone derivative and applications thereof as EGFR, BLK, and FLT3 inhibitor

    East China University of Science and Technology · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  8. US 9669014

    Small molecule inhibitors of superoxide dismutase expression

    Northwestern University · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  9. US 9670186

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  10. US 9669027

    Hepatitis C virus inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  11. US 9670140

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  12. US 9670215

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  13. US 9663519

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 30, 2017 · Expires May 25, 2037

    granted
  14. US 9662327

    Phenyl and pyridinyl substituted piperidines and piperazines as inhibitors of IDH1 mutants and their use in treating cancer

    Agios Pharmaceuticals, Inc. · Granted May 30, 2017 · Expires May 25, 2037

    granted
  15. US 9657023

    Polymorph of Syk inhibitors

    GILEAD CONNECTICUT, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  16. US 9657012

    FAAH inhibitors

    IRONWOOD PHARMACEUTICALS, INC. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  17. US 9650391

    N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 16, 2017 · Expires May 11, 2037

    granted
  18. US 9650381

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 16, 2017 · Expires May 11, 2037

    granted
  19. US 9643967

    Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 9, 2017 · Expires May 4, 2037

    granted
  20. US 9644004

    Peptide and peptidomimetic inhibitors

    RA PHARMACEUTICALS, INC. · Granted May 9, 2017 · Expires May 4, 2037

    granted
  21. US 9642898

    Use of serine protease inhibitors in the treatment of neutropenia

    MED DISCOVERY S.A. · Granted May 9, 2017 · Expires May 4, 2037

    granted
  22. US 9636329

    Methods of treating cancer with glut inhibitors and oxidative phosphorylation inhibitors

    Northwestern University · Granted May 2, 2017 · Expires Apr 27, 2037

    granted
  23. EP 3157548

    THERAPIE MIT EINEM FAKTOR-XII-INHIBITOR BEI EINER NEUROTRAUMATISCHEN STÖRUNG

    CSL BEHRING GMBH [DE] · Granted Apr 26, 2017 · Expires Apr 21, 2037

    granted
  24. US 9630914

    Multitarget FAAH and COX inhibitors and therapeutical uses thereof

    The Regents of the University of California · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted